Literature DB >> 12701056

Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: the Bogalusa Heart Study.

Sathanur R Srinivasan1, Maria G Frontini, Gerald S Berenson.   

Abstract

The occurrence of metabolic abnormalities related to insulin resistance syndrome in nondiabetic offspring of type 2 diabetic parents is known. However, information is lacking on the timing and the course of development of the components of this syndrome from childhood to adulthood in the offspring of parents with diabetes. This aspect was examined in a community-based cohort with (n = 303) and without (n = 1,136) a parental history of type 2 diabetes followed longitudinally since childhood (ages 4 to 17 years; mean follow-up period, 15 years) by repeated surveys. Offspring with parental diabetes versus those without such history had significantly excess generalized and truncal adiposity as measured by body mass index (BMI) and subscapular skinfold beginning in childhood, higher levels of fasting insulin and glucose and homeostasis model assessment index of insulin resistance (HOMA-IR) from adolescence, and higher levels of low-density lipoprotein (LDL) cholesterol and triglycerides and lower levels of high-density lipoprotein (HDL) cholesterol in adulthood. Many of these risk variables changed adversely at an increased rate in offspring of diabetic parents. In a multivariate analysis, parental diabetes was an independent predictor of longitudinal changes in adiposity, glucose, insulin, HOM-IR, systolic and diastolic blood pressure, and LDL cholesterol in the offspring, regardless of race and gender. As young adults, the offspring of diabetic parents had a higher prevalence of generalized (BMI > 30, 36% v 16%, P =.0001) and visceral (waist > 100 cm, 15% v 6%, P =.0001) obesity, hyperinsulinemia indicative of insulin resistance (insulin > 18 microU/mL, 15% v 8%, P =.0001), hyperglycemia (>or=110 mg/dL, 2% v 0.5%, P =.02), high LDL cholesterol (>or=160 mg/dL, 11% v 7%, P =.02), low HDL cholesterol (<40 mg/dL for males and <50 mg/dL for females, 40% v 31%, P =.004), high triglycerides (>or=150 mg/dL, 23% v 15%, P =.0001), and hypertension (>140/90 mm Hg, 11% v 6%, P =.004). Thus, the offspring of diabetic parents displayed excess body fatness beginning in childhood and accelerated progression of adverse risk profile characteristics of insulin resistance syndrome from childhood to young adulthood. These observations have important implications for early prevention and intervention. Copyright 2003 Elsevier, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12701056     DOI: 10.1053/meta.2003.50065

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  34 in total

1.  Sensitivity, specificity, and predictive values of pediatric metabolic syndrome components in relation to adult metabolic syndrome: the Princeton LRC follow-up study.

Authors:  Terry T-K Huang; Tonja R Nansel; Allen R Belsheim; John A Morrison
Journal:  J Pediatr       Date:  2007-10-22       Impact factor: 4.406

2.  Lower resting energy expenditure and fat oxidation in Native American and Hispanic infants born to mothers with diabetes.

Authors:  Kevin R Short; April M Teague; David A Fields; Timothy Lyons; Steven D Chernausek
Journal:  J Pediatr       Date:  2015-01-31       Impact factor: 4.406

3.  Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways.

Authors:  Gang Yuan; Juanjuan Deng; Tao Wang; Chunxia Zhao; Xizheng Xu; Peihua Wang; James W Voltz; Matthew L Edin; Xiao Xiao; Lee Chao; Julie Chao; Xin A Zhang; Darryl C Zeldin; Dao Wen Wang
Journal:  Endocrinology       Date:  2007-02-01       Impact factor: 4.736

4.  Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.

Authors:  B-J Ko; S M Kim; K H Park; H S Park; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2014-03-18       Impact factor: 5.095

5.  Pregnancy during adolescence has lasting adverse effects on blood lipids: a 10-year longitudinal study of black and white females.

Authors:  Erica P Gunderson; George Schreiber; Ruth Striegel-Moore; Mark Hudes; Stephen Daniels; Frank M Biro; Patricia B Crawford
Journal:  J Clin Lipidol       Date:  2011-12-23       Impact factor: 4.766

6.  Infant adiposity following a randomised controlled trial of a behavioural intervention in obese pregnancy.

Authors:  N Patel; K M Godfrey; D Pasupathy; J Levin; A C Flynn; L Hayes; A L Briley; R Bell; D A Lawlor; E Oteng-Ntim; S M Nelson; S C Robson; N Sattar; C Singh; J Wardle; S L White; P T Seed; L Poston
Journal:  Int J Obes (Lond)       Date:  2017-02-20       Impact factor: 5.095

7.  Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children.

Authors:  Joy C Bunt; P Antonio Tataranni; Arline D Salbe
Journal:  J Clin Endocrinol Metab       Date:  2005-03-29       Impact factor: 5.958

8.  Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls.

Authors:  Alison K Ventura; Eric Loken; Leann L Birch
Journal:  Pediatrics       Date:  2006-12       Impact factor: 7.124

9.  Influence of childhood parental history of type 2 diabetes on the pre-diabetic and diabetic status in adulthood: the Bogalusa Heart Study.

Authors:  Quoc Manh Nguyen; Sathanur R Srinivasan; Ji-Hua Xu; Wei Chen; Gerald S Berenson
Journal:  Eur J Epidemiol       Date:  2009-07-19       Impact factor: 8.082

10.  Frequency of secondary dyslipidemia in obese children.

Authors:  Ulrike Korsten-Reck; Katrin Kromeyer-Hauschild; Katrin Korsten; Manfred W Baumstark; Hans-H Dickhuth; Aloys Berg
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.